Document is current
Any future updates will be listed below
-
Authors
Pang, Yong Kek
Ismail, Ahmad Izuanuddin
Chan, Yoke Fun
Cheong, Adelina
Chong, Yoong Min
Doshi, Paras
Lau, Joanne Zhi Han
Khor, Jean
Wang, Lilian Phei Lian
Leong, Chee Loon
Musa, Aisya Natasya
Ng, Kee Sing
Poh, Mau Ern
Sam, I-Ching
Tan, Jiunn Liang
Zim, Mohd Arif Mohd
Taurel, Anne-Frieda
- License Information
-
More Information
Article History
Received: 2 March 2021
Accepted: 18 June 2021
First Online: 5 July 2021
Declarations
:
: The study protocol and amendments were approved by the Medical Research and Ethics Committee from the Malaysian Ministry of Health (reference KKM/NIHSEC/P17–852), the Medical Research Ethics Committee, University Malaya Medical Centre (ID NO: 2017465126) and the Universiti Teknologi Mara Research Ethics Committee (reference 600-IRMI (5/1/6. The study was conducted in accordance with Good Clinical Practice and Good Epidemiological Practice guidelines.
: Not applicable.
: AC, JK and A-FT are employees of Sanofi Pasteur and may hold shares and/or stock options in the company. AII, YFC, YMC, PD, JZHL, LPLW, CLL, ANM, KSN, MEP, JLT, and MAMZ have no conflicts to disclose. YKP received grant support from Sanofi Pasteur for the conduct of this study, and outside the submitted work, has previously received an honorarium to chair a webinar on behalf of Sanofi Pasteur. I-CS has received grant support from Sanofi Pasteur for the conduct of other studies and received honoraria to give talks.
